Cargando…
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas
BACKGROUND: The survival of glioblastoma patients is poor. Median survival after diagnosis is 15 months, despite treatment involving surgical resection, radiotherapy, and/or temozolomide chemotherapy. Identification of novel targets and stratification strategies of glioblastoma patients to improve p...
Autores principales: | van de Geer, Wesley S, Hoogstrate, Youri, Draaisma, Kaspar, Robe, Pierre A, Bins, Sander, Mathijssen, Ron H J, French, Pim, van de Werken, Harmen J G, de Vos, Filip Y F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760899/ https://www.ncbi.nlm.nih.gov/pubmed/35047820 http://dx.doi.org/10.1093/noajnl/vdab177 |
Ejemplares similares
-
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
por: Hoogstrate, Youri, et al.
Publicado: (2021) -
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
por: van Garderen, Karin A, et al.
Publicado: (2023) -
FASTAFS: file system virtualisation of random access compressed FASTA files
por: Hoogstrate, Youri, et al.
Publicado: (2021) -
Katdetectr: an R/bioconductor package utilizing unsupervised changepoint analysis for robust kataegis detection
por: Hazelaar, Daan M, et al.
Publicado: (2023) -
Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures
por: Verheul, Cassandra, et al.
Publicado: (2021)